GlassScriptPhysician profile
Susan B Butler
NPI 1881843233
$1,177.01
in general payments reported to CMS, 2019-2025
16 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical School (Nurse Practitioner) provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $336 · 2024: $523 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,177.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $302.04 | 2024 | Voquezna |
| Acadia Pharmaceuticals INC | $153.92 | 2024 | Daybue |
| Novo Nordisk INC | $127.55 | 2024-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $124.99 | 2023 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2023 | |
| Insulet Corporation | $124.99 | 2025 | Omnipod |
| Integra Lifesciences Corporation | $31.75 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cipher Pharmaceuticals US LLC | $29.05 | 2025 | Natroba, Spinosad |
| Glaxosmithkline, LLC. | $28.87 | 2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $21.75 | 2025 | Zepbound, Mounjaro |
| Vertex Pharmaceuticals Incorporated | $21.33 | 2024 | |
| Tandem Diabetes Care, INC. | $21.02 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Dynavax Technologies Corporation | $17.87 | 2023 | Heplisav-B |
| Exact Sciences Corporation | $16.88 | 2025 | The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $15.18 | 2023 | Eliquis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $14.83 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.